NASH becomes MASH as medical experts replace stigmatizing "non-alcoholic" liver disease terminology with dignity-focused ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

United States President Donald Trump has announced his administration is raising tariffs on steel imports from 25 percent to ...

NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation ...

A federal appeals court on May 29 allowed President Trump to continue collecting tariffs under an emergency powers law for ...

The biggest myth is that potatoes are “unhealthy” or fattening. Potatoes are nutrient powerhouses — packed with vitamins, ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat. Antioxidants and other compounds in coffee (even decaf) can help protect against ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.